These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27711011)

  • 21. Thymoglobulin and its use in renal transplantation: a review.
    Thiyagarajan UM; Ponnuswamy A; Bagul A
    Am J Nephrol; 2013; 37(6):586-601. PubMed ID: 23774740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody.
    Neuhaus P; Bechstein WO; Blumhardt G; Wiens M; Lemmens P; Langrehr JM; Lohmann R; Steffen R; Schlag H; Slama KJ
    Transplantation; 1993 Jun; 55(6):1320-7. PubMed ID: 8516819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-agent immunosuppression after liver transplantation: what is possible?
    Raimondo ML; Burroughs AK
    Drugs; 2002; 62(11):1587-97. PubMed ID: 12109922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of immunosuppressive therapy as risk factor for complications after liver transplantation.
    De Simone P; Carrai P; Coletti L; Ghinolfi D; Petruccelli S; Filipponi F
    Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):199-209. PubMed ID: 28624108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for immunosuppression in lung transplantation.
    Hopkins PM; McNeil K
    Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review article: use of induction therapy in liver transplantation.
    Rostaing L; Saliba F; Calmus Y; Dharancy S; Boillot O
    Transplant Rev (Orlando); 2012 Oct; 26(4):246-60. PubMed ID: 22863028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppression in liver transplantation.
    Everson GT; Trotter JF; Kugelmas M; Forman L
    Minerva Chir; 2003 Oct; 58(5):725-40. PubMed ID: 14603151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current strategies for immunosuppression following liver transplantation.
    Gotthardt DN; Bruns H; Weiss KH; Schemmer P
    Langenbecks Arch Surg; 2014 Dec; 399(8):981-8. PubMed ID: 24748543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.
    Helal I; Chan L
    Transplant Proc; 2011 Mar; 43(2):472-7. PubMed ID: 21440737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of thymoglobulin induction therapy in the prevention of acute graft rejection episodes following liver transplantation.
    Tchervenkov J; Flemming C; Guttmann RD; des Gachons G
    Transplant Proc; 1997 Nov; 29(7A):13S-15S. PubMed ID: 9366919
    [No Abstract]   [Full Text] [Related]  

  • 31. Preliminary results of immunosuppression with thymoglobuline pretreatment and hepatitis C virus recurrence in liver transplantation.
    De Ruvo N; Cucchetti A; Lauro A; Masetti M; Cautero N; Di Benedetto F; Dazzi A; Del Gaudio M; Ravaioli M; Zanello M; La Barba G; di Francesco F; Risaliti A; Ramacciato G; Pinna AD
    Transplant Proc; 2005; 37(6):2607-8. PubMed ID: 16182760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid.
    Uemura T; Schaefer E; Hollenbeak CS; Khan A; Kadry Z
    Transpl Int; 2011 Jul; 24(7):640-50. PubMed ID: 21429047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation.
    Wong TC; Lo CM; Fung JY
    Expert Opin Emerg Drugs; 2017 Jun; 22(2):123-136. PubMed ID: 28503959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study.
    Langrehr JM; Guckelberger O; Nüssler N; Radtke A; Lemmens HP; Jonas S; Lohmann R; Tullius S; Steinmüller T; Raakow R; Neumann U; Knoop M; Bechstein WO; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3204. PubMed ID: 8962241
    [No Abstract]   [Full Text] [Related]  

  • 35. Steroid avoidance or withdrawal for kidney transplant recipients.
    Pascual J; Zamora J; Galeano C; Royuela A; Quereda C
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005632. PubMed ID: 19160257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated.
    Chang GJ; Mahanty HD; Quan D; Freise CE; Ascher NL; Roberts JP; Stock PG; Hirose R
    Liver Transpl; 2000 Nov; 6(6):734-40. PubMed ID: 11084060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppression and modulation in liver transplantation.
    Encke J; Uhl W; Stremmel W; Sauer P
    Nephrol Dial Transplant; 2004 Jul; 19 Suppl 4():iv22-5. PubMed ID: 15240845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of monoclonal antibodies in renal transplantation.
    van den Hoogen MW; Hilbrands LB
    Immunotherapy; 2011 Jul; 3(7):871-80. PubMed ID: 21751955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimization of immunosuppression with thymoglobuline pre-treatment and HCV recurrence in liver transplantation.
    De Ruvo N; Cucchetti A; Lauro A; Masetti M; Di Benedetto F; Cautero N; La Barba G; Dazzi A; Di Francesco F; Molteni G; Romano A; Ramacciato G; Risaliti A; Pinna AD
    Clin Transplant; 2005 Apr; 19(2):255-8. PubMed ID: 15740564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.